4.2.4 Targeted therapies and immunotherapy
The state of medical therapies for cancer is constantly changing, and new treatments are routinely being trialled. Any decision on the use of targeted and immune therapies should include input from a medical oncologist and the patient.
For many patients, a clinical trial will be the best way to manage them, and access to clinical trials should always be considered.